SUNITINIB TREATMENT MODIFICATION IN FIRST-LINE METASTATIC RENAL CELL CARCINOMA: ANALYSIS OF A REAL-WORLD SWEDISH COHORT

被引：0
|
作者：
Jakobsson, M. [1 ]
Nilsson, F. [1 ]
Strambi, A. [2 ]
Arpegard, J. [2 ]
Dalen, J. [3 ]
机构：
[1] Pfizer Innovat AB, Sollentuna, Sweden
[2] Pfizer Innovat AB, Stockholm, Sweden
[3] ICON Plc, Stockholm, Sweden
来源：
VALUE IN HEALTH | 2022年 / 25卷 / 01期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
POSA26
引用
收藏
页码：S22 / S22
页数：1
相关论文
共 50 条
  • [1] Comparison of axitinib and sunitinib as first-line therapies for metastatic renal cell carcinoma: a real-world multicenter analysis
    Sakae Konishi
    Shingo Hatakeyama
    Toshiaki Tanaka
    Yoshinori Ikehata
    Toshikazu Tanaka
    Naoki Fujita
    Yusuke Ishibashi
    Hayato Yamamoto
    Takahiro Yoneyama
    Yasuhiro Hashimoto
    Kazuaki Yoshikawa
    Toshiaki Kawaguchi
    Naoya Masumori
    Hiroshi Kitamura
    Chikara Ohyama
    Medical Oncology, 2019, 36
  • [2] Comparison of axitinib and sunitinib as first-line therapies for metastatic renal cell carcinoma: a real-world multicenter analysis
    Konishi, Sakae
    Hatakeyama, Shingo
    Tanaka, Toshiaki
    Ikehata, Yoshinori
    Tanaka, Toshikazu
    Fujita, Naoki
    Ishibashi, Yusuke
    Yamamoto, Hayato
    Yoneyama, Takahiro
    Hashimoto, Yasuhiro
    Yoshikawa, Kazuaki
    Kawaguchi, Toshiaki
    Masumori, Naoya
    Kitamura, Hiroshi
    Ohyama, Chikara
    MEDICAL ONCOLOGY, 2019, 36 (01)
  • [3] Real-world treatment modification of first-line axitinib plus pembrolizumab in patients with metastatic renal cell carcinoma (mRCC)
    Zakharia, Y.
    Thomaidou, D.
    Li, B.
    Siu, G.
    Levin, R.
    Vlahiotis, A.
    Zanotti, G.
    ANNALS OF ONCOLOGY, 2021, 32 : S1423 - S1424
  • [4] Sunitinib Treatment Modification in First-Line Metastatic Renal Cell Carcinoma: Analysis of the STAR-TOR Registry
    Boegemann, Martin
    Hubbe, Marcus
    Thomaidou, Despina
    Blackburn, Stuart
    Bent-Ennakhil, Nawal
    Wood, Robert
    Bargo, Danielle
    ANTICANCER RESEARCH, 2018, 38 (11) : 6413 - 6422
  • [5] Real-world evidence on first-line treatment for metastatic renal cell carcinoma with non-clear cell and sarcomatoid histologies: are sunitinib and pazopanib interchangeable?
    Bonadio, Renata Colombo
    Velho, Pedro Isaacsson
    Marta, Guilherme Nader
    Narda, Mirella
    La Souza, Manoel Carlos
    Muniz, David Q. B.
    Bezerra, Regis O. F.
    Bispo, Raisa K. A.
    Faraj, Sheila F.
    Bastos, Diogo A.
    Dzik, Carlos
    ECANCERMEDICALSCIENCE, 2019, 13
  • [6] Efficacy of First-Line Targeted Therapy in Real-World Korean Patients with Metastatic Renal Cell Carcinoma: Focus on Sunitinib and Pazopanib
    Kim, Myung Soo
    Chung, Ho Seok
    Hwang, Eu Chang
    Jung, Seung Il
    Kwon, Dong Deuk
    Hwang, Jun Eul
    Bae, Woo Kyun
    Park, Jae Young
    Jeong, Chang Wook
    Kwak, Cheol
    Song, Cheryn
    Seo, Seong Il
    Byun, Seok-Soo
    Hong, Sung-Hoo
    Chung, Jinsoo
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2018, 33 (51)
  • [7] Sunitinib First-line Treatment in Metastatic Renal Cell Carcinoma: Costs and Effects
    Vuorinen, Riikka-Liisa
    Paunu, Niina
    Turpeenniemi-Hujanen, Taina
    Reunamo, Taina
    Jekunen, Antti
    Kataja, Vesa
    Sintonen, Harri
    Purmonen, Timo
    Kellokumpu-Lehtinen, Pirkko-Liisa
    ANTICANCER RESEARCH, 2019, 39 (10) : 5559 - 5564
  • [8] Sunitinib: the First to Arrive at First-Line Metastatic Renal Cell Carcinoma
    Vazquez, Sergio
    Leon, Luis
    Fernandez, Ovidio
    Lazaro, Martin
    Grande, Enrique
    Aparicio, Luis
    ADVANCES IN THERAPY, 2012, 29 (03) : 202 - 217
  • [9] Sunitinib: the First to Arrive at First-Line Metastatic Renal Cell Carcinoma
    Sergio Vázquez
    Luis León
    Ovidio Fernández
    Martín Lázaro
    Enrique Grande
    Luis Aparicio
    Advances in Therapy, 2012, 29 : 202 - 217
  • [10] Real-world assessment of clinical outcomes of first-line treatment in metastatic papillary renal cell carcinoma.
    De Vries, Manon
    Hamilou, Zineb
    Ghosh, Sunita
    Heng, Daniel Yick Chin
    Wood, Lori
    Basappa, Naveen S.
    Kollmannsberger, Christian K.
    Graham, Jeffrey
    Bhindi, Bimal
    Finelli, Antonio
    Bjarnason, Georg A.
    Bosse, Dominick
    Pouliot, Frederic
    Castonguay, Vincent
    Breau, Rodney H.
    Saleh, Ramy R.
    Winquist, Eric
    Lalani, Aly-Khan A.
    Soulieres, Denis
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (5_SUPPL)
12345